| Literature DB >> 30958590 |
Margo Slomp1,2, Evita Belegri1,2, Aurea S Blancas-Velazquez1,2, Charlene Diepenbroek1,2, Leslie Eggels1,2, Myrtille C R Gumbs1,2, Anil Joshi1,2, Laura L Koekkoek1,2, Khalid Lamuadni1,2, Muzeyyen Ugur1,2, Unga A Unmehopa1,2, Susanne E la Fleur1,2, Joram D Mul1,2.
Abstract
Humans have engineered a dietary environment that has driven the global prevalence of obesity and several other chronic metabolic diseases to pandemic levels. To prevent or treat obesity and associated comorbidities, it is crucial that we understand how our dietary environment, especially in combination with a sedentary lifestyle and/or daily-life stress, can dysregulate energy balance and promote the development of an obese state. Substantial mechanistic insight into the maladaptive adaptations underlying caloric overconsumption and excessive weight gain has been gained by analysing brains from rodents that were eating prefabricated nutritionally-complete pellets of high-fat diet (HFD). Although long-term consumption of HFDs induces chronic metabolic diseases, including obesity, they do not model several important characteristics of the modern-day human diet. For example, prefabricated HFDs ignore the (effects of) caloric consumption from a fluid source, do not appear to model the complex interplay in humans between stress and preference for palatable foods, and, importantly, lack any aspect of choice. Therefore, our laboratory uses an obesogenic free-choice high-fat high-sucrose (fc-HFHS) diet paradigm that provides rodents with the opportunity to choose from several diet components, varying in palatability, fluidity, texture, form and nutritive content. Here, we review recent advances in our understanding how the fc-HFHS diet disrupts peripheral metabolic processes and produces adaptations in brain circuitries that govern homeostatic and hedonic components of energy balance. Current insight suggests that the fc-HFHS diet has good construct and face validity to model human diet-induced chronic metabolic diseases, including obesity, because it combines the effects of food palatability and energy density with the stimulating effects of variety and choice. We also highlight how behavioural, physiological and molecular adaptations might differ from those induced by prefabricated HFDs that lack an element of choice. Finally, the advantages and disadvantages of using the fc-HFHS diet for preclinical studies are discussed.Entities:
Keywords: choice; chronic metabolic disease; diet preference; fat; obesity; sugar
Mesh:
Substances:
Year: 2019 PMID: 30958590 PMCID: PMC6593820 DOI: 10.1111/jne.12718
Source DB: PubMed Journal: J Neuroendocrinol ISSN: 0953-8194 Impact factor: 3.627
Metabolic, hormonal and behavioural adaptations with free‐choice diets compared to the control diet
| Diet | Body weight parameters | Hyperphagia | Meal pattern aspects | Glucose metabolism | Leptin dynamics | Central molecular adaptations after 1 week of diet | ||
|---|---|---|---|---|---|---|---|---|
| 1 week of diet | 4 weeks | 1 week of diet | 3‐8 weeks of diet | |||||
| fc‐HFHS |
BW ↑ | Persistent |
Size = |
InsBasal =,↑ |
InsBasal ↑ |
LepPlasma ↑ |
LepPlasma ↑ |
ARC |
| fc‐HF |
BW = | Transient |
Size ↑ |
InsBasal = |
InsBasal = |
LepPlasma =,↑ |
LepPlasma ↑ |
ARC |
| fc‐HS |
BW = | Transient |
Size ↓ |
InsBasal =,↑ |
InsBasal ↑ |
LepPlasma = |
LepPlasma ↑ |
ARC |
| nc‐HFHS |
BW = | Transient |
Size ↑ | |||||
| References | 33‐37,39‐42, 43,47 | 33‐41,43,47 |
|
|
|
|
|
|
Agrp, Agouti‐related peptide expression; ARC, arcuate nucleus of the hypothalamus; BW, body weight; EGP, endogenous glucose production; fc‐HF, free‐choice high‐fat; fc‐HFHS, free‐choice high‐fat high‐sucrose; fc‐HS, free‐choice high‐sucrose; FFA, plasma‐free fatty acids; GluBasal, basal glucose levels; GluGTT, plasma glucose excursions during glucose tolerance test; Hep‐IS, hepatic insulin sensitivity; InsBasal, basal insulin levels; InsGTT, plasma insulin excursions during glucose tolerance test; LepPlasma, plasma leptin levels; LR, leptin responsivity; nc‐HFHS, no‐choice high‐fat high‐sucrose; Npy, Neuropeptide Y expression; Per‐IS, peripheral insulin sensitivity; Pomc, Proopiomelanocortin expression; WAT, white adipose tissue.